Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Magnusson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Huntington'S Disease|July 27, 2014
A critical evaluation of inflammatory markers in Huntington's Disease plasmaEdina Silajdžić, Melinda Rezeli, Ákos Végvári, et al.
Neurobiology of Disease|December 3, 2014
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse modelsUlrike Träger, Ralph Andre, Anna Magnusson-Lind, et al.
Brain : a Journal of Neurology|January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulationUlrike Träger, Ralph Andre, Nayana Lahiri, et al.
The Journal of Experimental Medicine|July 16, 2008
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseMaria Björkqvist, Edward J Wild, Jenny Thiele, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Huntington'S Disease|July 27, 2014
A critical evaluation of inflammatory markers in Huntington's Disease plasmaEdina Silajdžić, Melinda Rezeli, Ákos Végvári, et al.
Neurobiology of Disease|December 3, 2014
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse modelsUlrike Träger, Ralph Andre, Anna Magnusson-Lind, et al.
Brain : a Journal of Neurology|January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulationUlrike Träger, Ralph Andre, Nayana Lahiri, et al.
The Journal of Experimental Medicine|July 16, 2008
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseMaria Björkqvist, Edward J Wild, Jenny Thiele, et al.
Pageof 2